Home  /  Resource Library  /  Rapid Improvement of Patient-Reported Outcomes with Venetoclax Plus Obinutuzumab in Patients with Previously Untreated CLL and Coexisting Conditions: A Prospective Analysis from the CLL14 Trial

Rapid Improvement of Patient-Reported Outcomes with Venetoclax Plus Obinutuzumab in Patients with Previously Untreated CLL and Coexisting Conditions: A Prospective Analysis from the CLL14 Trial

ASH 2019: Analysis of a phase III study investigating patient reported outcomes in patients treated with Venetoclax combined with Obinutuzumab for chronic lymphocytic leukemia.